Ascendis Receives a Grudging FDA Approval for Yorvipath, a Hormone Replacement Treatment

August 16, 2024

Mesoblast Resubmits BLA For Ryoncil Approval

July 10, 2024

$485M settlement for U.S. antitrust case against Sun Pharma’s Ranbaxy

March 29, 2022

Must Read

Digital Pharma Manufacturing Is Finally Delivering on Its Promise

June 15, 2026

How Commercial Teams Are Using AI to Improve Launch Performance

June 15, 2026

Sanofi Ends Phase 3 Trial of Riliprubart in CIDP After Interim Review

June 15, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Sanofi Ends Phase 3 Trial of Riliprubart in CIDP After Interim Review

Merck and Gilead Report Phase 3 HIV Success as Lung Cancer Trial Ends

Bial Says Goodbye to Asset Over Phase 2 Parkinson’s Failure

ADC Therapeutics’ Zynlonta Trial Results in Multiple Patient Deaths

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

Travere Licenses Civorebrutinib From Everest Medicines in Deal Worth Up to $1.14 Billion

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Digital Pharma Manufacturing Is Finally Delivering on Its Promise

How Commercial Teams Are Using AI to Improve Launch Performance

The New Playbook for Pharmaceutical Growth

Top 10 Operational Risks in Modern Clinical Trial Management

Editorial Team

Digital Pharma Manufacturing Is Finally Delivering on Its Promise

Editor Picks

Ascendis Receives a Grudging FDA Approval for Yorvipath, a Hormone Replacement Treatment

Mesoblast Resubmits BLA For Ryoncil Approval

$485M settlement for U.S. antitrust case against Sun Pharma’s Ranbaxy

Must Read

Digital Pharma Manufacturing Is Finally Delivering on Its Promise

How Commercial Teams Are Using AI to Improve Launch Performance

Sanofi Ends Phase 3 Trial of Riliprubart in CIDP After Interim Review

Hot Topics

About Us

Follow Us